Envestnet Asset Management’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,946
| Closed | -$260K | – | 4103 |
|
|
2022
Q2 | $260K | Sell |
7,946
-46,775
| -85% | -$1.48M | ﹤0.01% | 3441 |
|
|
2022
Q1 | $1.44M | Buy |
54,721
+13,386
| +32% | +$327K | ﹤0.01% | 2398 |
|
|
2021
Q4 | $981K | Buy |
41,335
+5,902
| +17% | +$146K | ﹤0.01% | 2641 |
|
|
2021
Q3 | $889K | Buy |
35,433
+4,385
| +14% | +$112K | ﹤0.01% | 2625 |
|
|
2021
Q2 | $807K | Buy |
+31,048
| New | +$845K | ﹤0.01% | 2675 |
|
|
2018
Q3 | – | Sell |
-1,181
| Closed | -$41K | – | 2841 |
|
|
2018
Q2 | $41K | Sell |
1,181
-11
| -0.9% | -$386 | ﹤0.01% | 2261 |
|
|
2018
Q1 | $40K | Sell |
1,192
-3,146
| -73% | -$99.6K | ﹤0.01% | 2211 |
|
|
2017
Q4 | $166K | Buy |
4,338
+266
| +7% | +$10.6K | ﹤0.01% | 1921 |
|
|
2017
Q3 | $154K | Sell |
4,072
-219
| -5% | -$7.73K | ﹤0.01% | 1930 |
|
|
2017
Q2 | $161K | Sell |
4,291
-8,510
| -66% | -$307K | ﹤0.01% | 1946 |
|
|
2017
Q1 | $504K | Buy |
12,801
+2,778
| +28% | +$104K | ﹤0.01% | 1516 |
|
|
2016
Q4 | $348K | Buy |
10,023
+2,295
| +30% | +$90.1K | ﹤0.01% | 1660 |
|
|
2016
Q3 | $304K | Sell |
7,728
-2,140
| -22% | -$85.4K | ﹤0.01% | 1832 |
|
|
2016
Q2 | $373K | Sell |
9,868
-94
| -0.9% | -$3.15K | ﹤0.01% | 1784 |
|
|
2016
Q1 | $383K | Buy |
9,962
+632
| +7% | +$23.5K | ﹤0.01% | 1763 |
|
|
2015
Q4 | $448K | Buy |
9,330
+1,054
| +13% | +$48.8K | ﹤0.01% | 1655 |
|
|
2015
Q3 | $326K | Buy |
8,276
+2,593
| +46% | +$110K | ﹤0.01% | 1794 |
|
|
2015
Q2 | $242K | Sell |
5,683
-4,118
| -42% | -$164K | ﹤0.01% | 2044 |
|
|
2015
Q1 | $387K | Buy |
9,801
+3,897
| +66% | +$144K | ﹤0.01% | 1667 |
|
|
2014
Q4 | $213K | Sell |
5,904
-2,889
| -33% | -$97K | ﹤0.01% | 993 |
|
|
2014
Q3 | $259K | Buy |
8,793
+8,626
| +5,165% | +$238K | ﹤0.01% | 999 |
|
|
2014
Q2 | $4K | Sell |
167
-146
| -47% | -$3.61K | ﹤0.01% | 2383 |
|
|
2014
Q1 | $8K | Sell |
313
-31
| -9% | -$781 | ﹤0.01% | 1980 |
|
|
2013
Q4 | $8K | Sell |
344
-57
| -14% | -$1.1K | ﹤0.01% | 1853 |
|
|
2013
Q3 | $6K | Buy |
+401
| New | +$5.36K | ﹤0.01% | 1884 |
|
Other funds holding NTUS
Envestnet Asset Management's NTUS Position: Q3 2022 in Review
Envestnet Asset Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 7,946 shares — an estimated $260K sold.
Envestnet Asset Management first reported a position in NTUS in Q3 2013 and held it in 25 quarters. The position peaked at $1.44M in Q1 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Envestnet Asset Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Envestnet Asset Management sold 7,946 Natus Medical Inc shares in Q3 2022, an estimated $260K.
- Envestnet Asset Management first reported a position in Natus Medical Inc in Q3 2013 and held it in 25 quarters.
- Envestnet Asset Management's Natus Medical Inc position peaked at $1.44M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.